https://pubmed.ncbi.nlm.nih.gov/34671772/Blood clots are a central feature of coronavirus disease-2019 (COVID-19) and can culminate in pulmonary embolism, stroke, and sudden death. However, it is not known how abnormal blood clots form in COVID-19 or why they occur even in asymptomatic and convalescent patients. Here we report that the Spike protein from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to the blood coagulation factor fibrinogen and induces structurally abnormal blood clots with heightened proinflammatory activity. SARS-CoV-2 Spike virions enhanced fibrin-mediated microglia activation and induced fibrinogen-dependent lung pathology. COVID-19 patients had fibrin autoantibodies that persisted long after acute infection. Monoclonal antibody 5B8, targeting the cryptic inflammatory fibrin epitope, inhibited thromboinflammation. Our results reveal a procoagulant role for the SARS-CoV-2 Spike and propose fibrin-targeting interventions as a treatment for thromboinflammation in COVID-19.
One-sentence summary: SARS-CoV-2 spike induces structurally abnormal blood clots and thromboinflammation neutralized by a fibrin-targeting antibody.
Similar articles
- SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19.
Grobbelaar LM, Venter C, Vlok M, Ngoepe M, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, Pretorius E.Biosci Rep. 2021 Aug 27;41(8):BSR20210611. doi: 10.1042/BSR20210611.PMID: 34328172 Free PMC article. - COVID-19 as a Blood Clotting Disorder Masquerading as a Respiratory Illness: A Cerebrovascular Perspective and Therapeutic Implications for Stroke Thrombectomy.
Janardhan V, Janardhan V, Kalousek V.J Neuroimaging. 2020 Sep;30(5):555-561. doi: 10.1111/jon.12770. Epub 2020 Aug 18.PMID: 32776617 Free PMC article. Review. - Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19).
Aleem A, Akbar Samad AB, Slenker AK.2022 Feb 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–.PMID: 34033342 Free Books & Documents. - Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.
Zhang J, Wu Q, Liu Z, Wang Q, Wu J, Hu Y, Bai T, Xie T, Huang M, Wu T, Peng D, Huang W, Jin K, Niu L, Guo W, Luo D, Lei D, Wu Z, Li G, Huang R, Lin Y, Xie X, He S, Deng Y, Liu J, Li W, Lu Z, Chen H, Zeng T, Luo Q, Li YP, Wang Y, Liu W, Qu X.Nat Microbiol. 2021 Jan;6(1):51-58. doi: 10.1038/s41564-020-00824-5. Epub 2020 Nov 16.PMID: 33199863 - Monoclonal antibody therapy in COVID-19.
Conti P, Pregliasco FE, Calvisi V, Caraffa Al, Gallenga CE, Kritas SK, Ronconi G.J Biol Regul Homeost Agents. 2021 Mar-Apr;35(2):423-427. doi: 10.23812/Conti_Edit_35_2_1.PMID: 33904269
